Literature DB >> 3092705

Arterial blood gases before, during, and after nitrous oxide:oxygen administration.

R D Stewart, M J Gorayeb, G H Pelton.   

Abstract

The use of nitrous oxide as an anesthetic or analgesic agent frequently raises concerns about the possibility of post-inhalational diffusion hypoxemia. We undertook a study in 20 healthy volunteers to determine whether hypoxemia occurs after the self-administration by face mask of a 50:50 mixture of nitrous oxide and oxygen for 15 minutes, followed by breathing room air. Blood gases were measured through an in-dwelling arterial cannula before, during, and after inhalation of the mixture, at time O, five, ten, and 15 minutes, and then 30 seconds, 45 seconds, 2 1/2 minutes, five, and ten minutes following room air breathing. Ten of the 20 subjects breathed a control gas, a mixture of 50% nitrogen: 50% oxygen. No subject demonstrated arterial hypoxemia at any time before, during, or after self-administration of the gas mixture. In the ten subjects who self-administered the control gas there were no significant differences in the PaO2 values while they breathed either gas at any corresponding sampling time. We conclude that diffusion hypoxia is not seen in normal subjects following self-administration of a mixture of 50:50 nitrous oxide and oxygen.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3092705     DOI: 10.1016/s0196-0644(86)80861-7

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  3 in total

1.  Noninvasive assessment of diffusion hypoxia following administration of nitrous oxide-oxygen.

Authors:  Arthur H Jeske; Clark W Whitmire; Chris Freels; Mike Fuentes
Journal:  Anesth Prog       Date:  2004

2.  Safety of inhalation of a 50% nitrous oxide/oxygen premix: a prospective survey of 35 828 administrations.

Authors:  Peter Onody; Pascal Gil; Martine Hennequin
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 3.  Nitrous oxide in emergency medicine.

Authors:  I O'Sullivan; J Benger
Journal:  Emerg Med J       Date:  2003-05       Impact factor: 2.740

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.